[1] Abdelhalim MM,Saafan GS,El-Sayed HS,Ghaith DM .2022 .In vitro antibacterial effect of probiotics against Carbapenamase-producing multidrug-resistant Klebsiella pneumoniae clinical isolates, Cairo, Egypt. , 97(1) : 19.
[2] Al-Sheboul SA,Al-Madi GS,Brown B,Hayajneh WA B .2023 .Prevalence of extended-spectrum β-lactamases in multidrug-resistant Klebsiella pneumoniae isolates in Jordanian Hospitals. J. Epidemiol. Glob. Health, 13(2) : 180-190.
[3] Aldhahri RK,Gabb SG,Shoaib OA,Almadani RM,Eljaaly K,Thabit AK K .2022 .Doxycycline vs. macrolides in combination with a β-lactam antibiotic for the treatment of community-acquired pneumonia in inpatients. Eur. J. Med. Res., 27(1) : 279.
[4] Annu and Sartaj Ali .2025 .Probiotics in the management of autoimmune disorders (Multiple Sclerosis): A New Approach. , 1(1) : 35-46.
[5] Ardebili A,Izanloo A,Rastegar M .2023 .Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant and difficult-to-treat drugresistant gram-negative infections: is it superior to polymyxin monotherapy? Expert Rev. , 21(4) : 387-429.
[6] Barbier F,Dupuis C,Buetti N,Schwebel C,Azoulay É,Argaud L,Cohen Y,Hong Tuan Ha V,Gainnier M,Siami S,Forel JM,Adrie C,de Montmollin É,Reignier J,Ruckly S,Zahar JR,Timsit JF JR .2024 .Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study. Crit. Care, 28(1) : 10.
[7] Bayatinejad G,Salehi M,Beigverdi R,Halimi S,Emaneini M,Jabalameli F M .2023 .In Vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients with ventilator-associated pneumonia. BMC Microbiol, 23(1) : 298.
[8] Bouza E .2021 .The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections. J. Antimicrob. Chemother., 76(Suppl 4) : iv38-iv45.
[9] Campaña-Duel E,Camprubí-Rimblas M,Areny-Balagueró A,Quero S,Artigas A,Ceccato A .2024 .Risk of multidrug-resistant pathogens in severe communityacquired pneumonia. Semin Respir. Crit. Care Med, 45(2) : 246-254.
[10] Cebrero-Cangueiro T,Labrador-Herrera G,CarreteroLedesma M,Herrera-Espejo S,Álvarez-Marín R,Pachón J,Cisneros JM,Pachón-Ibáñez ME .2022 .IgM-enriched immunoglobulin improves colistin efficacy in a pneumonia model by Pseudomonas aeruginosa. Life Sci. Alliance, 5(10) : e202101349.
[11] Chang Y,Jeon K,Lee SM,Cho YJ,Kim YS,Chong YP,Hong SB .2021 .The distribution of multidrug-resistant microorganisms and treatment status of hospitalacquired pneumonia/ventilator-associated pneumonia in adult intensive care Units: A prospective cohort observational study. J. Korean Med, 36(41) : e251.
[12] Cillóniz C,Torres A,Niederman MS .2021 .Management of pneumonia in critically ill patients. BMJ, 375 : e065871.
[13] Cui HM,Lin X,Liu YY,Shen YH .2021 .Comparison of different colistin regimens for the treatment of pneumonia caused by multidrug-resistant microorganisms: A systematic review and meta-analysis. Eur. Rev. Med, 25(16) : 5275-5292.
[14] Cui X,Du B,Feng J,Feng Y,Fan Z,Chen J,Cui J,Gan L,Fu T,Tian Z,Zhang R,Yan C,Zhao H,Xu W,Xu Z,Yu Z,Ding Z,Li Z,Chen Y,Xue G,Yuan J .2023 .A novel phage carrying capsule depolymerase effectively relieves pneumonia caused by multidrug-resistant Klebsiella aerogenes. J. Biomed. Sci., 30(1) : 75.
[15] Dan JM,Lehman SM,Al-Kolla R,Penziner S,Afshar K,Yung G,Golts E,Law N,Logan C,Kovach Z,Mearns G,Schooley RT,Aslam S,Crotty S S .2023 .Development of host immune response to bacteriophage in a lung transplant recipient on adjunctive phage therapy for a multidrug-resistant pneumonia. J. Infect. Dis., 227(3) : 311-316.
[16] Mitropoulou G,Koutsokera A,Csajka C,Blanchon S,Sauty A,Brunet JF,Garnier C,Resch G,Guery B .2022 .Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations. Eur. Respir. Rev., 31(166) : 220121.
[17] Mousavi SM,Babakhani S,Moradi L,Karami S,Shahbandeh M,Mirshekar M,Mohebi S,Moghadam MT .2021 .Bacteriophage as a novel therapeutic weapon for killing colistin-resistant multi-drug-resistant and extensively drug-resistant gram-negative bacteria. Curr. Microbiol., 78(12) : 4023-4036.
[18] Nielsen TB,Yan J,Slarve M,Lu P,Li R,Ruiz J,Lee B,Burk E,Talyansky Y,Oelschlaeger P,Hurth K,Win W,Luna BM,Bonomo RA,Spellberg B .2021 .Monoclonal antibody therapy against Acinetobacter baumannii. , 89(10) : e0016221.
[19] Rando E,Novy E,Sangiorgi F,De Pascale G,Fantoni M,Murri R,Roberts JA,Cotta MO .2024 .A systematic review of the pharmacokinetics and pharmacodynamics of novel beta-lactams and beta-lactam with betalactamase inhibitor combinations for the treatment of pneumonia caused by carbapenem-resistant gramnegative bacteria. Int. J. Antimicrob. Agents, 64(3) : 107266.
[20] Meschiari M,Asquier-Khati A,Tiseo G,Luque-Paz D,Murri R,Boutoille D,Falcone M,Mussini C,Tattevin P C .2024 .Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) societies of infectious diseases. Int. J. Antimicrob. Agents, 64(1) : 107186.
[21] Mazziotta C,Tognon M,Martini F,Torreggiani E,Rotondo JC .2023 .Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells, 12(1) : 184.
[22] Mansouri S,Savari M,Malakian A,Abbasi Montazeri E .2024 .High prevalence of multidrug-resistant Enterobacterales carrying extended-spectrum betalactamase and AmpC genes isolated from neonatal sepsis in Ahvaz, Iran. , 24(1) : 136.
[23] Mansour H,Ouweini AEL,Chahine EB,Karaoui LR .2021 .Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination. Am. J. Health Syst. Pharm., 78(8) : 674-683.
[24] Lorusso AB,Carrara JA,Barroso CDN,Tuon FF,Faoro H FF .2022 .Role of efflux pumps on antimicrobial resistance in Pseudomonas aeruginosa. Int. J. Mol. Sci, 23(24) : 15779.
[25] Liu C,Hong Q,Chang RYK,Kwok PCL,Chan HK .2022 .Phage-antibiotic therapy as a promising strategy to combat multidrug-resistant infections and to enhance antimicrobial efficiency. Antibiotics (Basel), 11(5) : 570.
[26] Liu C,Chen K,Wu Y,Huang L,Fang Y,Lu J,Zeng Y,Xie M,Chan EWC,Chen S,Zhang R .2022 .Epidemiological and genetic characteristics of clinical carbapenem-resistant Acinetobacter baumannii strains collected countrywide from hospital intensive care units (ICUs) in China. , 11(1) : 1730-1741.
[27] Lipszyc A,Szuplewska M,Bartosik D M .2022 .How do transposable elements activate expression of transcriptionally silent antibiotic resistance genes? Int. Mol. Sci, 23(15) : 8063.
[28] Leung V,Vincent C,Edens TJ,Miller M,Manges AR M .2018 .Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation for recurrent clostridium difficile infection. Clin. Infect. Dis., 66(3) : 456-457.
[29] Lai CC,Chen SY,Ko WC,Hsueh PR .2021 .Increased antimicrobial resistance during the COVID-19 pandemic. Int. J. Antimicrob. Agents, 57(4) : 106324.
[30] Kumar Roy R and Patra N .2020 .Configuration flipping in distal pocket of multidrug transporter mexb impacts the efflux inhibitory mechanism. Chem. phys. chem, 21(23) : 2516-2524.
[31] Kim JH,Lee Y,Kim I,Chang J,Hong S,Lee NK,Shum D,Baek S,Kim W,Jang S,Lee W .2024 .Reducing peptidoglycan crosslinking by chemical modulator reverts β-lactam resistance in methicillin-resistant Staphylococcus aureus. Adv. Sci. (Weinh), 11(28) : e2400858.
[32] Kim CJ,Song KH,Choi NK,Ahn J,Bae JY,Choi HJ,Jung Y,Lee SS,Bang JH,Kim ES,Moon SM,Song JE,Kwak YG,Chun SH,Kim YS,Park KH,Kang YM,Choe PG,Lee S,Kim HB .2022 .Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea. Sci. Rep, 12(1) : 13934.
[33] Khare T,Anand U,Dey A,Assaraf YG,Chen ZS,Liu Z,Kumar V .2021 .Exploring phytochemicals for combating antibiotic resistance in microbial pathogens. Front Pharmacol, 12 : 720726.
[34] Kaye KS,Shorr AF,Wunderink RG,Du B,Poirier GE,Rana K,Miller A,Lewis D,O'Donnell J,Chen L,Reinhart H,Srinivasan S,Isaacs R,Altarac D R .2023 .Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumanniicalcoaceticus complex: A multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK). Lancet Infect. Dis., 23(9) : 1072-1084.
[35] Kanj SS,Bassetti M,Kiratisin P,Rodrigues C,Villegas MV,Yu Y and van Duin D .2022 .Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections. Int. J. Antimicrob. Agents, 60(3) : 106633.
[36] Gohil SK,Septimus E,Kleinman K,Varma N,Avery TR,Heim L,Rahm R,Cooper WS,Cooper M,McLean LE,Nickolay NG,Weinstein RA,Burgess LH,Coady MH,Rosen E,Sljivo S,Sands KE,Moody J,Vigeant J,Rashid S,Gilbert RF,Smith KN,Carver B,Poland RE,Hickok J,Sturdevant SG,Calderwood MS,Weiland A,Kubiak DW,Reddy S,Neuhauser MM,Srinivasan A,Jernigan JA,Hayden MK,Gowda A,Eibensteiner K,Wolf R,Perlin JB,Platt R,Huang SS .2024 .Stewardship prompts to improve antibiotic selection for pneumonia: The INSPIRE Randomized Clinical Trial. , 331(23) : 2007-2017.
[37] Ghani R,Mullish BH,Davies FJ,Marchesi JR .2022 .How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrugresistant infection. Clin. Microbiol, 28(4) : 502-512.
[38] Gan L,Fu H,Tian Z,Cui J,Yan C,Xue G,Fan Z,Du B,Feng J,Zhao H,Feng Y,Xu Z,Fu T,Cui X,Zhang R,Du S,Liu S,Zhou Y,Zhang Q,Cao L,Yuan J .2022 .Bacteriophage effectively rescues pneumonia caused by prevalent multidrug-resistant Klebsiella pneumoniae in the early stage. Microbiol, 10(5) : e0235822.
[39] Falcone M,Tiseo G,Menichetti F G .2021 .Communityacquired pneumonia owing to multidrug-resistant pathogens: A step toward an early identification. Ann. Am. Thorac. Soc., 18(2) : 211-213.
[40] El Shamy AA,Zakaria Z,Tolba MM,Salah Eldin N,Rabea AT,Tawfick MM,Nasser HA .2021 .AmpC β- Lactamase variable expression in common multidrugresistant nosocomial bacterial pathogens from a tertiary hospital in Cairo, Egypt. Int. J. Microbiol., : 6633888.
[41] Do AD,Quang HP,Phan QK .2024 .Probiotic cell-free supernatant as effective antimicrobials against Klebsiella pneumoniae and reduce antibiotic resistance development. Int. Microbiol., 28(4) : 623-632.
[42] Ding Y,Hao J,Xiao W,Ye C,Xiao X,Jian C,Tang M,Li G,Liu J,Zeng Z J .2023 .Role of efflux pumps, their inhibitors, and regulators in colistin resistance. Front Microbiol, 14 : 1207441.
[43] Deng Y,Chen L,Yue M,Huang X,Yang Y,Yu H Y .2022 .Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia. BMC Infect. Dis., 22(1) : 795.
[44] Rathor N,Bahadur T,Thakur CK,Bamola VD,Das BK,Chaudhry R .2023 .Bacteriophages as therapeutic & disinfectant agents to tackle multidrug-resistant Acinetobacter baumannii. Indian J. Med. Res., 157(6) : 549-558.
[45] Ray M,Manjunath A,Halami PM .2023 .Effect of probiotics as an immune modulator for the management of COVID-19. , 205(5) : 182.
[46] Ray M,Manjunath A,Halami PM .2022 .Prevalence of polymyxin resistance through the food chain, the global crisis. J. Antibiot. (Tokyo), 75(4) : 185-198.
[47] Reva ON,Korotetskiy IS,Joubert M,Shilov SV,Jumagaziyeva AB,Suldina NA,Ilin AI .2020 .The effect of iodine-containing nano-micelles, FS-1, on antibiotic resistance, gene expression and epigenetic modifications in the genome of multidrug resistant MRSA strain Staphylococcus aureus ATCC BAA-39. , 11 : 581660.
[48] Rong F,Liu Z,Yang P,Wu F,Sun Y,Sun X,Zhou J .2023 .Epidemiological and Molecular Characteristics of bla (NDM-1) and bla (KPC-2) Co-Occurrence Carbapenem-Resistant Klebsiella pneumoniae. Infect. Drug Resist, 16 : 2247-2258.
[49] Russo TA,Carlino-MacDonald U,Alvarado CL,Davies CJ,Barnes O,Trivedi G,Mathur P,Hutson A,Adams FG,Zang M,Ascari A,Eijkelkamp BA .2023 .Penicillin binding protein 7/8 is a potential drug target in carbapenem-resistant acinetobacter baumannii. Antimicrob, 67(1) : e0103322.
[50] Savinova OS,Glazunova OA,Moiseenko KV,Begunova AV,Rozhkova IV,Fedorova TV .2021 .Exoproteome analysis of antagonistic interactions between the probiotic bacteria limosilactobacillus reuteri LR1 and Lacticaseibacillus rhamnosus F and Multidrug Resistant Strain of Klebsiella pneumonia. Int J. Mol. Sci, 22(20) : 10999.
[51] Shen Z,Guo Z,Zhou L,Wang Y,Zhang J,Hu J,Zhang Y .2020 .Biomembrane induced in situ self-assembly of peptide with enhanced antimicrobial activity. Biomater. Sci., 8(7) : 2031-2039.
[52] Shields RK,Stellfox ME,Kline EG,Samanta P,Van Tyne D P .2022 .Evolution of imipenem-relebactam resistance following treatment of multidrug-resistant Pseudomonas aeruginosa Pneumonia. Clin. Infect. Dis., 75(4) : 710-714.
[53] Shortridge D,Kantro V,Castanheira M .2023 .Meropenem-Vaborbactam activity against U.S. multidrug-resistant enterobacterales strains, including carbapenem-resistant isolates. Microbiol, 11(1) : e0450722.
[54] Singh M,Kaur L,Bajaj R,Arodhia S R .2021 .Double carbapenem regimen used as salvage therapy to treat multidrug-resistant Klebsiella pneumoniae causing ventilator-associated pneumonia. Adv. Respir. Med, 89(2) : 203-206.
[55] Thi MTT,Wibowo D,Rehm BHA D .2020 .Pseudomonas aeruginosa Biofilms. Int. J. Mol. Sci, 21(22) : 8671.
[56] Tumbarello M,Raffaelli F,Giannella M,Mantengoli E,Mularoni A,Venditti M,De Rosa FG,Sarmati L,Bassetti M,Brindicci G,Rossi M,Luzzati R,Grossi PA,Corona A,Capone A,Falcone M,Mussini C,Trecarichi EM,Cascio A,Guffanti E,Russo A,De Pascale G,Tascini C,Gentile I,Losito AR,Bussini L,Corti G,Ceccarelli G,Corcione S,Compagno M,Giacobbe DR,Saracino A,Fantoni M,Antinori S,Peghin M,Bonfanti P,Oliva A,De Gasperi A,Tiseo G,Rovelli C,Meschiari M,Shbaklo N,Spanu T,Cauda R,Viale P .2021 .Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing K. pneumoniae Infections: A retrospective observational multicenter study. Clin. Infect. Dis., 73(9) : 1664-1676.
[57] Uruén C,Chopo-Escuin G,Tommassen J,Mainar-Jaime RC,Arenas J .2020 .Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics (Basel), 10(1) : 3.
[58] Van der Weide H,Ten Kate MT,Vermeulen-de Jongh DMC,Van der Meijden A,Wijma RA,Boers SA,Van Westreenen M,Hays JP,Goessens WHF,BakkerWoudenberg I WHF .2020 .Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats. Antibiotics (Basel), 9(3) : 109.
[59] Veloo Y,Thahir SSA,Rajendiran S,Hock LK,Ahmad N,Muthu V,Shaharudin R V .2022 .Multidrug-resistant gram-negative bacteria and extended-spectrum β- lactamase-producing Klebsiella pneumoniae from the poultry farm environment. Microbiol, 10(3) : e0269421.
[60] Wang L,Xu C,Si L,Gan G,Lin B,Yu Y .2024 .Polymyxin-containing regimens for treating of pneumonia caused by multidrug-resistant gram-negative bacteria: Mind the breakpoints and the standardization of nebulization therapy. Crit. Care, 28(1) : 324.
[61] Wen J,Xiao Y,Zhao M,Yang C,Hu W C .2024 .Effects of Clarithromycin and Ketoconazole on FK506 Metabolism in Different CYP3A4 Genotype recombinant metabolic enzyme systems. Curr. Drug Metab, 25(2) : 174-177.
[62] Wu B,Peng M,Tong Y,Wang X,Ding Y,Cheng X .2023 .Distribution of bacteria and risk factors in patients with multidrug-resistant pneumonia in a single center rehabilitation ward. Medicine (Baltimore), 102(36) : e35023.
[63] Yaghoubi S,Zekiy AO,Krutova M,Gholami M,Kouhsari E,Sholeh M,Maleki F Z .2022 .Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: Narrative review. Eur. J. Clin. Microbiol, 41(7) : 1003-1022.
[64] Yu Y,Zhao Y,He Y,Pang J,Yang Z,Zheng M,Yin R M .2022 .Inhibition of efflux pump encoding genes and biofilm formation by sub-lethal photodynamic therapy in methicillin susceptible and resistant Staphylococcus aureus. , 39 : 102900.
[65] Zhang X,Cui X,Jiang M,Huang S,Yang M .2023 .Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis. J. Crit. Care, 77 : 154315.
[66] Zheng JY,Huang SS,Huang SH,Ye JJ .2020 .Colistin for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J. Microbiol. Immunol. Infect., 53(6) : 854-865.
[67] Zhu Z,Hu Z,Li S,Fang R,Ono HK,Hu DL .2023 .Molecular characteristics and pathogenicity of staphylococcus aureus exotoxins. Int. J. Mol. Sci, 25(1) : 395.